Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Enova International, Inc.ENVA · Entity 3836 | Chief Financial Officer | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Enova International, Inc.
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy) with limited SARSEC Table II · derivative / convertible security · Conversion / exercise price $257.79 · Expires 2033-08-05 | Direct | 1,500 |
Reported balance
After 2026-08-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 1,500 · Balance 1,500 F1: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
F2: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
F3: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 1,500 | $0.00 Strike: $257.79 | $0.00 |
DisclosureSEC source: 0002104070-26-000005 · ownership.xml · derivative · entry 1 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common stock; par value $0.00001 per share · 1,500 shares Expires 2033-08-05 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:33 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,176 | $0.00 Strike: $166.88 | $0.00 |
DisclosureSEC source: 0001193125-26-226985 · ownership.xml · derivative · entry 2 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,176 Underlying: Common stock; par value $0.00001 per share · 2,176 shares Expires 2033-05-13 F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029. Read SEC document |
| May 10, 2026 Filed May 15, 2026 20:33 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 544 | $174.90 | $95,145.60 |
DisclosureSEC source: 0001193125-26-226985 · ownership.xml · nonDerivative · entry 1 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,547 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,105 | $0.00 Strike: $157.79 | $0.00 |
DisclosureSEC source: 0001193125-26-051542 · ownership.xml · derivative · entry 2 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,105 Underlying: Common stock; par value $0.00001 per share · 2,105 shares Expires 2033-02-11 F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028 and February 11, 2029. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantCommon stock, par value $0.00001 per share | 3,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-051542 · ownership.xml · nonDerivative · entry 1 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,091 F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028, February 11, 2029 and February 11, 2030. Read SEC document |
| February 08, 2026 Filed Feb 9, 2026 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 246 | $161.10 | $39,630.60 |
DisclosureSEC source: 0001193125-26-043122 · ownership.xml · nonDerivative · entry 4 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,815 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 08, 2026 Filed Feb 9, 2026 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 242 | $161.10 | $38,986.20 |
DisclosureSEC source: 0001193125-26-043122 · ownership.xml · nonDerivative · entry 3 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,061 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 269 | $161.10 | $43,335.90 |
DisclosureSEC source: 0001193125-26-043122 · ownership.xml · nonDerivative · entry 2 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,303 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 158 | $159.78 | $25,245.24 |
DisclosureSEC source: 0001193125-26-043122 · ownership.xml · nonDerivative · entry 1 Cornelis Scott · CIK 0002104070 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,572 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.